心脏术后严重脓肿分枝杆菌全球暴发的分子流行病学研究
研究对来自瑞士、德国、荷兰和英国的21例心脏手术相关患者及218株加热-冷却单元(HCU)等来源的脓肿分枝杆菌分离株进行全基因组测序。系统发育分析显示患者分离株与LivaNova品牌HCU及其生产 site 的分离株聚为同一亚组,提示HCU生产环节污染可能是全球严重感染暴发的源头。
要点
- 心脏手术相关脓肿分枝杆菌感染与LivaNova品牌HCU污染相关。
- 全基因组测序可追溯暴发源头至生产环节。
- 需加强HCU防护措施并提高临床医生警觉性。
核心结论
- LivaNova工厂HCU的脓肿分枝杆菌污染可能是瑞士、德国、荷兰、英国、美国及澳大利亚心脏手术相关严重感染的源头。
研究设计与样本
- 分子流行病学研究纳入21例心脏手术相关患者的24株脓肿分枝杆菌分离株。
- 同时纳入218株来自医院不同类型HCU、LivaNova和Maquet品牌HCU生产 site 及无关环境与患者的分离株,以及8株胞内分枝杆菌分离株。
- 采用Illumina和Pacific Biosciences二代及三代全基因组测序,并与已发表基因组比较。
主要发现
- 基于250株分离株全基因组测序的系统发育分析揭示两个主要脓肿分枝杆菌群。
- 心脏手术相关患者分离株均归入群1,除1株外形成一 distinct 亚组。
- 该亚组还包括来自美国的11例心脏手术相关患者分离株、多数LivaNova HCU分离株及1株来自其生产 site 的分离株。
- 其他HCU及无关患者分离株在系统发育树中分布更广泛。
临床怎么用
- 临床医生应警惕心脏手术后脓肿分枝杆菌感染,并追溯HCU暴露史。
- 对HCU采取防护措施以保障患者安全。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Since 2013, over 100 cases of Mycobacterium chimaera prosthetic valve endocarditis and disseminated disease were notified in Europe and the USA, linked to contaminated heater-cooler units (HCUs) used during cardiac surgery. We did a molecular epidemiological investigation to establish the source of these patients' disease. METHODS: We included 24 M chimaera isolates from 21 cardiac surgery-related patients in Switzerland, Germany, the Netherlands, and the UK, 218 M chimaera isolates from various types of HCUs in hospitals, from LivaNova (formerly Sorin; London, UK) and Maquet (Rastatt, Germany) brand HCU production sites, and unrelated environmental sources and patients, as well as eight Mycobacterium intracellulare isolates. Isolates were analysed by next-generation whole-genome sequencing using Illumina and Pacific Biosciences technologies, and compared with published M chimaera genomes. FINDINGS: Phylogenetic analysis based on whole-genome sequencing of 250 isolates revealed two major M chimaera groups. Cardiac surgery-related patient isolates were all classified into group 1, in which all, except one, formed a distinct subgroup. This subgroup also comprised isolates from 11 cardiac surgery-related patients reported from the USA, most isolates from LivaNova HCUs, and one from their production site. Isolates from other HCUs and unrelated patients were more widely distributed in the phylogenetic tree. INTERPRETATION: HCU contamination with M chimaera at the LivaNova factory seems a likely source for cardiothoracic surgery-related severe M chimaera infections diagnosed in Switzerland, Germany, the Netherlands, the UK, the USA, and Australia. Protective measures and heightened clinician awareness are essential to guarantee patient safety. FUNDING: Partly funded by the EU Horizon 2020 programme, its FP7 programme, the German Center for Infection Research (DZIF), the Swiss National Science Foundation, the Swiss Federal Office of Public Health, and National Institute of Health Research Oxford Health Protection Research Units on Healthcare Associated Infection and Antimicrobial Resistance.
引用
- van Ingen J, Kohl TA, Kranzer K, et al. Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study. Lancet Infect Dis. 2017. PMID: 28711585. doi:10.1016/S1473-3099(17)30324-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。